艾尔斯-PFN1的表达会损害iPSC衍生的微质中的囊泡降解
bioRxiv : the preprint server for biology
|July 3, 2023
概括
突变性profilin-1 (PFN1) 导致微质中的脂质问题和受损的吞细胞,这是像ALS这样的神经退行性疾病中的关键细胞. 针对自道的向可能会恢复微质细胞功能.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 细胞生物学 细胞生物学
- 遗传学 遗传学 是一个
背景情况:
- 微质在神经退行性疾病中至关重要,但它们的功能障碍机制尚不清楚.
- 与神经退行性疾病相关的基因可以影响微质功能.
研究的目的:
- 为了研究与肌缩性侧面硬化症 (ALS) 相关的profilin-1 (PFN1) 突变如何影响微质性质.
- 探索自途径在PFN1相关微质功能障碍中的作用.
主要方法:
- 使用了人类诱导的多能干细胞衍生微状细胞 (iMG),具有PFN1突变.
- 评估ALS-PFN1IMG中的脂质代谢和细胞化.
- 研究了突变PFN1和酸-3酸 (PI3P) 在自途径之间的相互作用.
主要成果:
- 在ALS-PFN1的IMG中显示了脂质代谢障碍和降低的细胞能力.
- 突变的PFN1增强了与PI3P的结合,破坏了自.
- 拉帕米辛治疗通过诱导自流恢复了ALS-PFN1 iMGs中的细胞形成.
结论:
- 人类IMG是研究神经退行性疾病的宝贵模型.
- 与ALS相关的PFN1突变通过自道中断损害了微质功能.
- 微质囊泡降解途径代表神经退行性疾病的潜在治疗点.
更多相关视频
09:48In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages
Published on: February 14, 2021
5.6K
11:19Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
Published on: August 18, 2022
4.1K
相关概念视频
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...